annb0t
Top 20
ResMed (NYSE:RMD) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on year to $1.28 billion. Its non-GAAP profit of $2.43 per share was 5.2% above analystsâ consensus estimates.
Is now the time to buy ResMed? Find out in our full research report.
ResMed (RMD) Q4 CY2024 Highlights:
Revenue: $1.28 billion vs analyst estimates of $1.27 billion (10.3% year-on-year gro...
>>> Read more: ResMed (NYSE:RMD) Posts Better-Than-Expected Sales In Q4 But Stock Drops
Medical device company ResMed (NYSE:RMD) announced better-than-expected revenue in Q4 CY2024, with sales up 10.3% year on year to $1.28 billion. Its non-GAAP profit of $2.43 per share was 5.2% above analystsâ consensus estimates.
Is now the time to buy ResMed? Find out in our full research report.
ResMed (RMD) Q4 CY2024 Highlights:
Revenue: $1.28 billion vs analyst estimates of $1.27 billion (10.3% year-on-year gro...
>>> Read more: ResMed (NYSE:RMD) Posts Better-Than-Expected Sales In Q4 But Stock Drops
